Island Pharmaceuticals Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported revenue was AUD 0.004559 million. Net loss was AUD 1.61 million compared to AUD 0.846022 million a year ago.

Basic loss per share from continuing operations was AUD 0.0198 compared to AUD 0.0104 a year ago.